Prognostic implications of PD-L1 expression in patients with angiosarcoma.

Lee, Jii Bum; Ahn, Beung-Chul; Kim, Seung Hyun; Lee, Young Han; Han, Jung Woo; Jeon, Min Kyung; Kim, Soo Hee; Kim, Hyo Song

Lee, Jii Bum; Ahn, Beung-Chul; Kim, Seung Hyun; Lee, Young Han; Han, Jung Woo; Jeon, Min Kyung; Kim, Soo Hee; Kim, Hyo Song.

Afiliação

Lee JB; Department of Internal Medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Ahn BC; Department of Internal Medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Kim SH; Department of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea.
Lee YH; Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.
Han JW; Department of Pediatric Hemato-Oncology, Yonsei University College of Medicine, Seoul, Korea.
Jeon MK; Department of Internal Medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Kim SH; Pathology Center, Seegene Medical Foundation, Seoul, Korea.
Kim HS; Department of Internal Medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

Future Sci OA ; 7(5): FSO691, 2021 Mar 02.

Article em En | MEDLINE | ID: mdl-34046193

Palavras-chave

PD-L1; angiosarcoma; chemotherapy; overall survival; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Future Sci OA Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google